Solvemed Company

Revolutionising neurology diagnostics and drug discovery with the power of Artificial Intelligence.

Total Funding: 4403981.0
Last Funding Type: Seed
Investors Number: 7.0
Estimated Revenue: Less than $1M
Founded Date: 2019-09-01
Industry: Neurodegenerative disease diagnosis and treatment
Last Funding Date: 2022-10-05
Funding Status: Seed
Headquarters: Cambridge, Cambridgeshire, United Kingdom